Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.04 (-3.43%)
Close on Oct 19, 2026Market cap $5.53MP/E –Yield –
Imunon free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Imunon's free cash flow for the twelve months ending Dec 31, 2025 was -$14.18M. For fiscal 2025 it was -$14.18M. The highest annual figure on record is -$7.18M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.18M | – |
| FY2024 | Dec 31, 2024 | -$18.88M | – |
| FY2023 | Dec 31, 2023 | -$19.47M | – |
| FY2022 | Dec 31, 2022 | -$23.36M | – |
| FY2021 | Dec 31, 2021 | -$16.54M | – |
| FY2020 | Dec 31, 2020 | -$15.64M | – |
| FY2019 | Dec 31, 2019 | -$20.61M | – |
| FY2018 | Dec 31, 2018 | -$7.18M | – |
| FY2017 | Dec 31, 2017 | -$16.68M | – |
| FY2016 | Dec 31, 2016 | -$18.44M | – |
| FY2015 | Dec 31, 2015 | -$20.94M | – |
| FY2014 | Dec 31, 2014 | -$22.03M | – |
| FY2013 | Dec 31, 2013 | -$9.58M | – |
| FY2012 | Dec 31, 2012 | -$22.76M | – |
| FY2011 | Dec 31, 2011 | -$23.32M | – |
| FY2010 | Dec 31, 2010 | -$13.37M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$3.66M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.44M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.05M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.70M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.85M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.86M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.97M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.95M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.98M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.63M | -193.4% |
| Q3 FY2019 | Sep 30, 2019 | -$4.55M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.74M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.68M | – |
| Q4 FY2018 | Dec 31, 2018 | $6.03M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.27M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.25M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.23M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.11M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.15M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.68M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.73M | – |
| Q2 FY2016 | Jun 30, 2016 | -$4.27M | – |
| Q1 FY2016 | Mar 31, 2016 | -$4.77M | – |
See a number that looks wrong?